Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 469-110-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral, dermal and inhalation toxicity of AD-1000 were determined, according to current guidelines, to be >2000 mg/kg bw, >2000 mg/kg bw and >5.2 mg/l, respectively.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 5 000 mg/m³
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Oral toxicity
In a study performed according to OECD 423, EC B.1 tris, EPA and JMAFF guidelines, AD-1000 was administered by oral gavage to rats at 2000 mg/kg bw. The observation period was 14 days. No mortality and clinical signs occurred. The body weight gain shown by the animals over the study period was considered to be normal, and no macroscopic abnormalities were found. Therefore, the LD50 was determined to be >2000 mg/kg bw. According to the OECD 423 test guideline the LD50 cut off value was considered to exceed the 5000 mg/kg bw.
Dermal toxicity
In a study performed according to OECD 402, EC B.3, EPA and JMAFF guidelines, AD-1000 was administered by a single dermal application (occlusive) to rats at 2000 mg/kg bw for 24 hours. The observation period was 14 days. No mortality occurred. Hunched posture was observed in one male, and chromodacryorrhoea in one male and one female. These animals had recovered from the symptoms between days 2 and 3. The body weight gain shown by the animals over the study period was considered to be normal, and no macroscopic abnormalities were found. Erythema, scales and scabs were seen in the treated skin-area of 5/10 animals during the observation period. Therefore, the LD50 was determined to be >2000 mg/kg bw.
Inhalation toxicity
In a study performed according to OECD 403, EC B.2, EPA and JMAFF guidelines, AD-1000 was administered by inhalation for 4 hours to rats (5/sexe), nose only. The observation period was 14 days. The mean actual concentration was 5.2 +/- 0.4 mg/l, the nominal concentration was 14.6 mg/l with a generation efficiency (ratio of actual and nominal concentration) of 35.6%. The mean mass aerodynamic diameter (MMAD) was determined twice, being 1.8 microm. on both occasions. One female was found dead 3 hours post-treatment, no further mortality occurred. No clinical signs were noted during exposure. After exposure, hunched posture, piloerection, ptosis and slow breathing were noted among the majority of the animals. Laboured respiration was noted among the majority of the males and rales were noted in one female. The surviving animals had recovered from the symptoms between days 2 and 3. The body weight gain shown by the surviving animals over the study period was considered to be normal and no macroscopic abnormalities were found. Macroscopic post mortem examination of the animal that died during the study showed granular, gray-white contents in the trachea, gray-white discolouration of the tongue and many, dark red foci on the lungs. Therefore, the LC50 was determined to be >5 mg/l.
Justification for classification or non-classification
Based on the studies present, AD-1000 does not have to be classified according to 67/548/EEC and the CLP Regulation (EC) No 1272/2008 for acute oral, dermal or inhalation toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.